Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dixon JA et al. – EGF Trap–Eye is a novel anti–VEGF therapy, with Phase I and II trial data indicating safety, tolerability and efficacy for the treatment of neovascular AMD. Two Phase III clinical trials comparing VEGF Trap–Eye to ranibizumab are currently continuing and will provide vital insight into the clinical applicability of this drug.

Today in Other Drugs...keeping you current

Inflammatory breast cancer: what are the treatment options
Expert Opinion in Pharmacotherapy, 12/08/09

A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management
Pharmacoepidemiology and Drug Safety, 12/08/09

Activities of Memphis-area hospitals to meet National Patient Safety Goals for warfarin therapy
American Journal of Health-System Pharmacy, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address